ImExHS Limited (ASX:IME)
0.390
0.00 (0.00%)
Apr 28, 2026, 3:34 PM AEST
ImExHS Revenue
In the year 2025, ImExHS had annual revenue of 28.97M AUD with 9.17% growth. ImExHS had revenue of 15.31M in the half year ending December 31, 2025, with 38.89% growth.
Revenue
28.97M
Revenue Growth
+9.17%
P/S Ratio
0.73
Revenue / Employee
99.90K
Employees
290
Market Cap
21.09M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.97M | 2.43M | 9.17% |
| Dec 31, 2024 | 26.54M | 6.65M | 33.44% |
| Dec 31, 2023 | 19.89M | 2.64M | 15.32% |
| Dec 31, 2022 | 17.24M | 3.82M | 28.45% |
| Dec 31, 2021 | 13.43M | 2.44M | 22.25% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TrivarX | -95.36K |
| Resonance Health | 13.84M |
| Pathkey.AI | 290.26K |
| Intelicare Holdings | 945.45K |
| PainChek | 3.44M |
| Adheris Health | 40.60M |
| Beamtree Holdings | 28.90M |
| Emyria | 2.29M |